HAIXI PHARMA (02637)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| RSM (China) | 04-Aug-26 | |||
| Deloitte | 04-Aug-26 | The Company decided to align the preparation of its financial reports in accordance with China Accounting Standards for Business Enterprises (CASBE) starting from the interim financial report for the period ended 30 June 2026. Since RSM China CPA LLP is a PRC external auditor is qualified to provide audit services to mainland China-incorporated issuers listed in Hong Kong, the Company proposed to terminate the engagement of Deloitte Touche Tohmatsu and appoint RSM China CPA LLP as its external auditor. |